ly 293111 has been researched along with Experimental Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adrian, TE; Ding, XZ; Hennig, R; Pour, PM; Standop, J; Tong, WG; Witt, RC | 1 |
1 other study(ies) available for ly 293111 and Experimental Neoplasms
Article | Year |
---|---|
Leukotriene B4 receptor antagonist LY293111 inhibits proliferation and induces apoptosis in human pancreatic cancer cells.
Topics: Animals; Apoptosis; Benzoates; Blotting, Western; Cell Division; Female; Humans; In Situ Nick-End Labeling; In Vitro Techniques; Leukotriene B4; Mice; Mice, Inbred BALB C; Microscopy, Polarization; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Neoplasm Transplantation; Neoplasms, Experimental; Pancreatic Neoplasms; Receptors, Leukotriene B4; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Tumor Cells, Cultured | 2002 |